Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.7K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

511
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
511
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Mechanisms and Current Research Status of Salvianolic Acid B in the Treatment of Cardiovascular Diseases.

Journal of agricultural and food chemistry·2026
Same author

Icariin from <i>Epimedium</i>: A Multi-Target Natural Flavonoid and Its Multi-Disease Therapeutic Potential.

The American journal of Chinese medicine·2026
Same author

From Plants to Bone Health: A Review on Polysaccharides from Agricultural and Medicinal Botanicals for Osteoporosis Management.

Journal of agricultural and food chemistry·2026
Same author

From Toxicity Assessment to In Vivo Validation: Exploring the Molecular Mechanisms of Triclosan-Induced Liver Injury.

Chemical research in toxicology·2025
Same author

Curcumin Ameliorated Glucocorticoid-Induced Osteoporosis While Modulating the Gut Microbiota and Serum Metabolome.

Journal of agricultural and food chemistry·2025
Same author

Effects of <i>Lactobacillus plantarum</i> and <i>Weissella viridescens</i> on the Gut Microbiota and Serum Metabolites of Mice with Antibiotic-Associated Diarrhea.

Nutrients·2023

Related Experiment Video

Updated: Feb 12, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

5.9K

Gut Microbiota and Type 1 Diabetes.

Hui Han1,2, Yuying Li3,4, Jun Fang5

  • 1Key Laboratory of Agro-Ecological Processes in Subtropical Region, Institute of Subtropical Agriculture, Chinese Academy of Sciences, National Engineering Laboratory for Pollution Control and Waste Utilization in Livestock and Poultry Production, Changsha 410128, China. hanhui16@mails.ucas.ac.cn.

International Journal of Molecular Sciences
|March 28, 2018
PubMed
Summary

Type 1 diabetes (T1D) is rising globally. This study reviews how gut microbiota, or gut bacteria, impacts T1D development and suggests targeting these microbes may offer new treatments.

Keywords:
dietgut microbiotahormonesimmune responsetype 1 diabetes

More Related Videos

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
07:54

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

Published on: July 25, 2017

14.8K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K

Related Experiment Videos

Last Updated: Feb 12, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

5.9K
A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
07:54

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice

Published on: July 25, 2017

14.8K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K

Area of Science:

  • Microbiology
  • Immunology
  • Endocrinology

Background:

  • Type 1 diabetes (T1D) incidence is rapidly increasing worldwide, posing a significant public health challenge.
  • Factors including diet, genetics, and gut microbiota are implicated in T1D development.
  • The gut microbiota significantly influences host homeostasis and metabolic health, with dysbiosis linked to T1D pathogenesis.

Purpose of the Study:

  • To provide an updated overview of the role of gut microbiota in type 1 diabetes.
  • To discuss the potential mechanisms through which gut microbiota influences T1D.
  • To explore the therapeutic potential of targeting gut microbiota for T1D.

Main Methods:

  • Literature review and synthesis of recent research findings.
  • Analysis of studies investigating the gut microbiome in relation to T1D.
  • Discussion of proposed mechanistic links between gut dysbiosis and insulin dysfunction.

Main Results:

  • Altered gut bacterial composition (dysbiosis) is strongly associated with T1D pathogenesis.
  • Gut microbiota influences immune responses and metabolic processes relevant to T1D.
  • Evidence suggests a causal link between gut microbiota alterations and T1D development.

Conclusions:

  • Gut microbiota plays a critical role in the development and progression of type 1 diabetes.
  • Targeting the gut microbiota represents a promising therapeutic strategy for T1D.
  • Further research into specific microbial targets and interventions is warranted.